News

Two speakers take part in a fireside chat on stage at the Investing in Oxford 2026 healthcare investor event in San Francisco, with Oxford University Innovation branding displayed behind them.

Investing in Oxford: showcasing Oxford life sciences during JPM week in San Francisco

16th January 2026

All News

Oxford University Innovation (OUI) returned to San Francisco on Tuesday 13 January 2026 to host its third annual ‘Investing in Oxford’ event during the J.P. Morgan Healthcare Conference week. Bringing together international investors, corporates and Oxford spinouts, the evening highlighted why Oxford remains one of the world’s most compelling places to invest in life sciences innovation.

ImpactU secures €300,000 to boost health-focused social ventures in low-resource settings

1st December 2025

All News

ImpactU has received €300,000 from Financière de Tubize to expand its support for university-linked social ventures developing sustainable health solutions in low-resource regions.

Oxford-Cambridge Innovation Showcase brings leading life sciences spinouts and global investors together in London

25th November 2025

All News

A gathering of investors and life sciences ventures from Oxford and Cambridge showcased the region’s research strengths and its growing impact on global health.

OUI marks UCSF Silver Anniversary with almost £3 billion raised by spinouts

30th September 2025

All News

For 25 years, Oxford’s University Challenge Seed Fund has helped to create almost 100 companies

Quantum leap: the story behind the University of Oxford’s highest-value quantum computing spinout acquisition

17th September 2025

All News

Oxford Ionics has been acquired by US-listed IonQ in a landmark $1.075 billion deal - the largest quantum acquisition to emerge from the University of Oxford to date.

Oxford University Innovation spinout OrganOx to be acquired by Terumo for a record $1.5bn

25th August 2025

All News

Oxford University Innovation spinout OrganOx is set to be acquired by Terumo Corporation in a landmark $1.5 billion deal. The agreement marks the largest acquisition of an Oxford spinout to date and highlights the strength of OUI’s spinout model, which has supported OrganOx from its inception in 2008 through to its position today as a leader in advanced organ preservation.

Medhesion wins StEP Ignite 2025 as students showcase the future of innovation

30th July 2025

All News

From biotech to quantum and AI-driven music tech, this year’s StEP Ignite cohort proved that Oxford’s next generation of innovators are building bold solutions for real-world challenges.

Oxford spinout OrganOx wins the MacRobert Award 2025

11th July 2025

All News

OrganOx, a spinout from the University of Oxford formed with support from Oxford University Innovation, has been awarded the UK’s most prestigious engineering prize for its organ preservation technology that is transforming transplant outcomes worldwide.

Thelior Bio: rethinking gut health from the inside out

9th July 2025

All News

Thelior Bio working on new class of therapies

Bright Sparks and Big Ideas: Jamie Awards 2025 celebrate innovation with purpose

24th June 2025

All News

Celebrating student ingenuity with real-world purpose, the 2025 Jamie Ferguson Innovation Awards spotlighted Oxford’s next generation of problem-solvers - recognising research that not only breaks scientific ground but aims to change lives.

News

Ready to get in touch?